Form 8-K - Current report:
SEC Accession No. 0001102624-04-000019
Filing Date
2004-02-10
Accepted
2004-02-10 12:30:19
Documents
2
Period of Report
2004-02-10
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 IMMUCELL CORPORATION 8K immucell8k.htm 8-K 3210
3 IMMUCELL CORPORATION PRESS RELEASE immucellcorporation.htm EX-99.1 CHARTER 7495
  Complete submission text file 0001102624-04-000019.txt   12408
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 04580718
SIC: 2835 In Vitro & In Vivo Diagnostic Substances